{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:45:34Z","timestamp":1793699134044,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061734"],"award-info":[{"award-number":["U01DK061734"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK119460"],"award-info":[{"award-number":["K23DK119460"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["P01HL147835"],"award-info":[{"award-number":["P01HL147835"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01AA029019"],"award-info":[{"award-number":["U01AA029019"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R01DK106419"],"award-info":[{"award-number":["R01DK106419"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R01DK124318"],"award-info":[{"award-number":["R01DK124318"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["P30DK120515"],"award-info":[{"award-number":["P30DK120515"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U01DK130190"],"award-info":[{"award-number":["U01DK130190"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R01DK121378"],"award-info":[{"award-number":["R01DK121378"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR001442"],"award-info":[{"award-number":["5UL1TR001442"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhep.2025.05.030","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T02:41:09Z","timestamp":1749782469000},"page":"1023-1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1720-4355","authenticated-orcid":false,"given":"Federica","family":"Tavaglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Antonio","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-0942","authenticated-orcid":false,"given":"Veeral","family":"Ajmera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert","family":"Madamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricki","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-9991","authenticated-orcid":false,"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.05.030_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.030_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.030_bib3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2025.05.030_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","volume":"81","author":"Marti-Aguado","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.030_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S2468-1253(23)00450-8","article-title":"The role of past and present alcohol use in steatotic liver disease","volume":"9","author":"\u00c5berg","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.05.030_bib6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2022.04.040","article-title":"Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease","volume":"77","author":"Staufer","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2025.05.030_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.dld.2024.01.195","article-title":"You can\u2019t handle the truth! Comparing serum phosphatidylethanol to self-reported alcohol intake in chronic liver disease patients","volume":"56","author":"Scholten","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2025.05.030_bib8","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.jhep.2022.07.007","article-title":"Considerations in the search for under-reported alcohol consumption in NAFLD","volume":"78","author":"Hagstr\u00f6m","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.030_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/alcalc\/agl027","article-title":"PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients","volume":"41","author":"Aradottir","year":"2006","journal-title":"Alcohol Alcohol"},{"issue":"7","key":"10.1016\/j.jhep.2025.05.030_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.dld.2024.02.011","article-title":"Positive phosphatidyl-ethanol test in liver disease patients: you can\u2019t handle the truth","volume":"56","author":"Al-Salmay","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2025.05.030_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000003","article-title":"Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD","volume":"7","author":"Blomdahl","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.05.030_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00365521.2016.1239759","article-title":"Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease","volume":"52","author":"Hagstr\u00f6m","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2025.05.030_bib13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/apt.18506","article-title":"Head-to-Head comparison between phosphatidylethanol versus indirect alcohol biomarkers for diagnosis of MetALD versus MASLD: a prospective study","volume":"61","author":"Tavaglione","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.05.030_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1369-1600.2006.00040.x","article-title":"Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin","volume":"12","author":"Hartmann","year":"2007","journal-title":"Addict Biol"},{"key":"10.1016\/j.jhep.2025.05.030_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/alcalc\/agv038","article-title":"Phosphatidylethanol compared with other blood tests as a biomarker of moderate alcohol consumption in healthy volunteers: a prospective randomized study","volume":"50","author":"Kechagias","year":"2015","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jhep.2025.05.030_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512175","article-title":"Phosphatidylethanol (PEth) in blood as a marker of unhealthy alcohol use: a systematic Review with novel molecular insights","volume":"24","author":"Perilli","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jhep.2025.05.030_bib17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1136\/gutjnl-2024-332917","article-title":"Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA","volume":"73","author":"Yang","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.05.030_bib18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.15288\/jsa.1982.43.1157","article-title":"Reliability of alcohol use indices. The lifetime drinking history and the MAST","volume":"43","author":"Skinner","year":"1982","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.jhep.2025.05.030_bib19","series-title":"The alcohol use disorders identification test: guidelines for use in primary care","author":"Babor","year":"2001"},{"key":"10.1016\/j.jhep.2025.05.030_bib20","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/j.jhep.2025.05.030_bib21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/add.13341","article-title":"Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries","volume":"111","author":"Kalinowski","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.jhep.2025.05.030_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(24)00380-7","article-title":"Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective","author":"D\u00edaz","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.05.030_bib23","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhep.2025.05.030_bib24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.05.030_bib25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/1556-4029.13874","article-title":"The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines","volume":"63","author":"Ulwelling","year":"2018","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.jhep.2025.05.030_bib26","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.030_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.030_bib28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2024.01.006","article-title":"Misclassified alcohol-related liver disease is common in presumed metabolic dysfunction-associated steatotic liver disease and highly increases risk for future cirrhosis","volume":"22","author":"Nasr","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.05.030_bib29","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0168-8278(24)00708-6","article-title":"SAT-263 Resmetirom treatment of a subgroup of patients with possible MetALD enrolled in MAESTRO-NASH, a phase 3 NASH\/MASH serial liver biopsy study","volume":"80","author":"Harrison","year":"2024","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2025.05.030_bib30","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/liv.16034","article-title":"Metabolic characteristics of patients with MetALD: caveats of a new definition","volume":"44","author":"Petrie","year":"2024","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jhep.2025.05.030_bib31","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/apt.70006","article-title":"Editorial: revolutionising steatotic liver disease diagnosis with phosphatidylethanol\u2014authors\u2019 reply","volume":"61","author":"Tavaglione","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.05.030_bib32","article-title":"Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake","volume":"7","author":"Hansen","year":"2025","journal-title":"JHEP Rep"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782502269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782502269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:48:19Z","timestamp":1763668099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882782502269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S016882782502269X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.05.030","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}